RCSA
PFE icon

REYL & Cie S.A.’s Pfizer PFE Stock Holding History

REYL & Cie S.A.’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$920K Buy
+32,663
New +$854K 1.06% 25

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

REYL & Cie S.A.'s PFE Position: Q2 2026 in Review

REYL & Cie S.A. opened a new position in Pfizer (PFE) in Q2 2026: 32,663 shares worth $920K. The stake represents 1.06% of the portfolio and ranks #25 among its holdings.

2,840 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • REYL & Cie S.A. held 32,663 shares of Pfizer worth $920K as of Q2 2026.
  • Pfizer was a new REYL & Cie S.A. position in Q2 2026.
  • Pfizer made up 1.06% of REYL & Cie S.A.'s portfolio in Q2 2026, its #25 holding.
  • 2,840 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on REYL & Cie S.A.'s 13F filing for Q2 2026, filed 2 Oct 2026.